Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial https://t.co/9zHeUIda7o
Results from the Highlow RCT presented by @MiddeldorpS at #ISTH2022 comparing intermediate vs low dose LMWH in pregnant women who have had previous VTE. Antenatal no difference between dose for VTE, postpartum intermediate dose may be more protective.
To all the new PGY1s starting today or in the next few days, introduce yourself proudly and deservedly as Doctor. There is always help, you are not alone, and as @baileympaterson once told me, the morning always comes. You got this! #MedTwitter
🆕 The BLEEDING RISK Study, now published in @BloodAdvances, derived the new CHAP model (creatinine, hemoglobin, age, antiplatelet use) to identify unprovoked #VTE patients at high risk of major bleeding & compared its performance with 5 existing scores.
https://t.co/cOaE1eGvfL
It takes zero extra effort to use patient-centred language, and it can make a huge difference. People are people first and foremost, with so much more to them than their diagnoses. We must never forget that. https://t.co/a0be46zROU
Frequent reason for consultation: What is the risk of bleeding for patients with elevated INR from chronic liver disease compared to those on warfarin?
@KSanfilippoMD@JTHjournal
https://t.co/OvUD5OKfJj
Here's one: ascorbic acid is an early cofactor in the biosynthesis of catecholamines.
This trivial detail helped us diagnose scurvy in a patient who presented with postural hypotension.
https://t.co/zdDTFydxr5
I usually curse ab exercises but today I curse the Russian twist that much more. @SweatWithKayla and #fitness goers, how about just calling them ab twists from now on?
If we could get back to a world where we could be friendly with one another and not have our cars vandalized in a grocery store parking lot that would be great…
The #gratitude expressed from patients and families and among coworkers this week has completely warmed my ♥️. Even in the darkest (and coldest and covidiest) days, there is kindness and hope. #MedTwitter
Forty persons in whom thrombosis and thrombocytopenia had developed after an initial ChAdOx1 nCoV-19 vaccination were given a second dose of a #COVID19vaccine, most commonly BNT162b2. None had a recurrence of thrombosis and thrombocytopenia. #IDTwitter https://t.co/cXDPz8zPDV
Myocarditis and Pericarditis After Vaccination for COVID-19 https://t.co/kFosyejg3u via @JAMA_current
1-1.8/100,000 risk of vaccine related myo/pericarditis. No deaths. Median 2 days of hospitalization.
Helpful data when speaking with patients about risks.
I work in a hospital setting in Calgary, Alberta.
This anonymous note--from a high school student--was left on the windshield of one of my co-workers in an attempt to raise the spirits of health care workers who have been so brutally demoralized lately.
“the AHS critical triage protocol — designed to help doctors make decisions about who gets life-saving care when there aren't enough ventilators and ICU beds for everyone who needs them — will likely be invoked soon as well.” —do people really not understand the gravity of this?!
Risk of pregnancy loss at 6 to < 20 weeks of gestation after #COVID19 vaccination soon after conception or in early pregnancy was consistent with expected risk of spontaneous abortion. #SARSCoV2#Covid19Vaccines https://t.co/NTY2naYs1d